Breast cancer is considered as a fatal illness and it is known to be the number one cause of cancer death in women. According to American cancer society, about 1.3 million new breast cancer cases are diagnosed every year which consists of 465,000 deaths. In order to successfully tackle this devastating disease, we should encourage innovative scientists to research cancer at its most basic stage. In other words, breast cancer investigation work must be conducted at its molecular level. Also, besides the governments, private organizations must offer flexible budget to scientists who will be doing breast cancer research work.
Proper financial support of breast cancer investigation projects; can not only result to better prevention methods but it can also assist towards earlier detection techniques and new anticancer medication and treatments.
Not so long ago, scientists who are researching towards breast cancer research project, have developed and successfully tried a breast cancer vaccine which is possibly to cure women with treatment – resistant HER2 – positive breast cancer and therefore be capable to prevent cancer remission. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to avoid initial development of such tumours. Now therapies such as trastuzumab and lapatimib are used in treating breast cancer patients. But, it was lately noticed that a large group of patients build up a resistance in trastuzumab and lapatimib. HER2 receptors are identified to promote a particularly destructive kind of tumour that includes an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body’s own cells. It offers a cancer combating gene into cells, which subsequently form immune system proteins and also cancer ? fighting cells.
According to the primary researcher Wei – Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by utilizing so – called naked DNA from genes that makes the HER2 receptor. This DNA is combined with an immune stimulant. The method involved in the making of the vaccine, is called as electro oration.
In this process, pulses of electricity were utilized in order to inject the vaccine into the leg muscles in mice. The genes moved towards the cells, which then produced HER2 receptors that led to activation of antibodies and immune cells called Killer T cells.
